Report as of 29 Dec 2019

BGF World Healthscience A2

Morningstar® Category Morningstar® Benchmark Fund Benchmark
Sector Equity Healthcare MSCI World/Health Care NR USD MSCI World/Health Care NR USD
Used throughout report

Investment Objective Performance

The World Healthscience Fund seeks to maximise total
192
return. The Fund invests globally at least 70% of its total
169
assets in the equity securities of companies whose
predominant economic activity is in healthcare, 146

pharmaceuticals, medical technology and supplies and 123

the development of biotechnology. Currency exposure 100
is flexibly managed.
2014   2015   2016   2017   2018   2019-11 
24.40 4.56 -8.02 21.78 4.98 20.82 Fund
18.10 6.60 -6.81 19.80 2.51 19.18 Benchmark
17.90 5.30 -10.00 20.38 -3.31 17.84 Category

Risk Measures Trailing Returns % Fund Bmark Cat Quarterly Returns % Q1 Q2 Q3 Q4

3Y Alpha 1.89 3Y Sharpe Ratio 1.15 3 Months 13.15 14.62 14.74 2019 8.27 1.74 0.39 -
3Y Beta 0.95 3Y Std Dev 11.76 6 Months 13.42 13.20 11.58 2018 -1.82 5.90 11.22 -9.21
3Y R-Squared 90.29 3Y Risk Avg 1yr 29.73 25.59 25.16 2017 9.49 7.63 0.92 2.41
3Y Info Ratio 0.39 5Y Risk Avg 3 Years Annualised 16.51 14.84 12.99 2016 -9.44 5.82 1.12 -5.09
3Y Tracking Error 3.72 10Y Risk Avg 5 Years Annualised 9.08 8.38 6.66 2015 7.97 1.67 -11.47 7.59
Calculations use MSCI World/Health Care NR USD (where applicable)
10 Years Annualised 13.10 12.26 10.87
Data Through 27/12/2019

Portfolio 30/11/2019

Asset Allocation % Net Equity Style Box™ Mkt Cap % Fund America Europe Asia
Stocks 98.45 Giant 50.91
Large Mid
Size

Bonds 0.00 Large 35.09

Cash 1.55 Medium 12.20
Other 0.00 Small 1.61
Small

Value Blend Growth Micro 0.18

Style
Average Mkt Cap Fund
(Mil)
Ave Mkt Cap USD 66,303.6 <25 25-50 50-75 >75

3
Top Holdings Stock Sector Weightings % Fund World Regions % Fund
Holding Name Sector %
h Cyclical 0.52 Americas 70.01
UnitedHealth Group Inc d 5.98 r Basic Materials 0.52 United States 70.01
Abbott Laboratories d 4.52 t Consumer Cyclical - Canada 0.00
Roche Holding AG Dividend... d 4.26 y Financial Services - Latin America 0.00
Merck & Co Inc d 4.15 u Real Estate - Greater Europe 24.52
AstraZeneca PLC d 4.07
j Sensitive 0.00 United Kingdom 7.49
Sanofi SA d 3.56 i Communication Services - Eurozone 5.53
Thermo Fisher Scientific Inc d 3.17 o Energy - Europe - ex Euro 11.50
Stryker Corp d 2.75 p Industrials - Europe - Emerging 0.00
Amgen Inc d 2.63 a Technology - Africa 0.00
Medtronic PLC d 2.61 Middle East 0.00
k Defensive 99.48
Assets in Top 10 Holdings % 37.70 s Consumer Defensive - Greater Asia 5.47
Total Number of Equity Holdings 102 d Healthcare 99.48 Japan 3.95
Total Number of Bond Holdings 0 f Utilities - Australasia 0.00
Asia - Developed 0.00
Asia - Emerging 1.52

Operations

Fund Company BlackRock (Luxembourg) SA Share Class Size (mil) 3,298.15 USD Minimum Initial Purchase -
Phone +44 20 77433000 (27/12/2019) Minimum Additional Purchase -
Website www.blackrock.com Domicile Luxembourg Ongoing Charge 1.82%
Inception Date 06/04/2001 Currency USD Performance Fee -
Manager Name - UCITS Yes NAV (27/12/2019) USD 51.88
Manager Start Date 01/04/2011 Inc/Acc Acc Total Net Assets (mil) (30/11/2019) 5,186.63 USD
ISIN LU0122379950 Dividend Paying Frequency -
12 Month Yield (30/11/2019) 0.00%

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may ®
not be copied or redistributed except as specifically authorised;(3) do not constitute investment advice;(4) are provided solely for informational purposes; (5) are not warranted to be complete, accurate or timely; and (6) may
be drawn from fund data published on various dates. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it
ß
and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well
as up.